bioMerieux Exploring QS Improvements Following IVD Facility Inspections
This article was originally published in The Gray Sheet
Executive Summary
bioMerieux is bringing in consultants to help resolve quality system issues identified by FDA after an April inspection of the firm's Durham, N.C. facility, the firm reported in a recent earnings release